ClinicalTrials.Veeva

Menu

Effect of Smoking on Retinal Vessel Morphology and Functionality

S

San Donato Group (GSD)

Status

Completed

Conditions

Smokers

Treatments

Behavioral: Cigarette Smoking

Study type

Interventional

Funder types

Other

Identifiers

NCT07261176
SMOKE-DVA

Details and patient eligibility

About

The study aims at evaluating the effect of smoking activity on anatomy and functionality of retinal blood vessels using optical coherence tomography angiography (OCT-A) and dynamic vessel analysis (DVA).

This is a low-risk, single-center, case-control, interventional clinical trial. Forty healthy subjects were enrolled: 20 healthy volunteers with regular daily tobacco activity (approximately 10 cigarettes per day for 5-10 years) and 20 healthy volunteers with no tobacco activity as controls.

Each subject underwent comprehensive ophthalmologic examination including OCT-A, DVA, and retinal vessel analysis (RVA) at baseline. Examinations were repeated for the smoking group at 3 and 30 minutes after smoking activity, and for controls at 8 and 35 minutes after baseline to assess examination variability.

The primary outcomes assessed changes in retinal perfusion and retinal vascular response after cigarette smoking compared to controls.

Enrollment

40 patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults of both sexes (age 20 to 30 years old)
  • Healthy volunteers who can understand and sign informed consent
  • For Smokers Group: Regular daily tobacco activity (approximately 10 cigarettes per day, smoking duration 5-10 years, using cigarettes with 0.8 grams nicotine content)
  • For Control Group: No tobacco activity as normal life habit
  • Willing to abstain from tobacco activity for 24 hours prior to baseline examination
  • Willing to avoid vasoconstrictor substances (coffee, alcohol) prior to examinations

Exclusion criteria

  • Inability to follow planned procedures
  • Opacity of dioptric media (lens, cornea, or vitreous) that prevents execution of examinations
  • Known allergies that do not allow pupillary dilation
  • Ocular pathologies
  • Systemic hypertension
  • Diabetes mellitus
  • Myopia greater than -8.0 Diopters (D)
  • Hyperopia greater than +5.0 D
  • Astigmatism greater than -3.0 D

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Smokers Group
Experimental group
Description:
Twenty healthy volunteers with regular daily tobacco activity (approximately 10 cigarettes per day, smoking duration 5-10 years, using cigarettes with 0.8 grams nicotine content). Participants underwent OCT-A, DVA, and RVA examinations at baseline, 3 minutes, and 30 minutes after smoking one cigarette.
Treatment:
Behavioral: Cigarette Smoking
Non-smokers Control Group
No Intervention group
Description:
Twenty healthy volunteers with no tobacco activity as normal life habit. Control participants underwent the same OCT-A, DVA, and RVA examinations at baseline, 8 minutes, and 35 minutes (corresponding timepoints without smoking) to assess examination variability and learning effects.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems